You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Transarterial

Showing 1 - 25 of 530
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Transarterial Radioembolization in COlorectal MEtastasis of

Not yet recruiting
  • Transarterial Radioembolization
  • Therasphere
  • (no location specified)
Sep 7, 2023

Hepatocellular Carcinoma (HCC) Trial (Durvalumab, Bevacizumab, Transarterial Radioembolization (TARE))

Not yet recruiting
  • Hepatocellular Carcinoma (HCC)
  • (no location specified)
Sep 11, 2023

CT Imaging for Guiding PA-TACE for HCC

Recruiting
  • Carcinoma, Hepatocellular
  • postoperative adjuvant transarterial chemoembolization
  • Guangzhou, Guangdong, China
    ZhuJiang Hospital of Southern Medical University
Nov 30, 2023

Hemoptysis Trial in Wuhan (Transarterial CT angiography)

Recruiting
  • Hemoptysis
  • Transarterial CT angiography
  • Wuhan, Hubei, China
    Union Hospital affiliated to Tongji Medical College of Huazhong
Mar 26, 2023

Carcinoma, Hepatocellular Trial (Therasphere 90Y, Microwave Ablation)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • Therasphere 90Y
  • Microwave Ablation
  • (no location specified)
Jul 12, 2023

Transarterial Therapies+Donafenib + Anti-PD-1 Antibody for uHCC:

Not yet recruiting
  • Hepatocellular Carcinoma Non-resectable
  • transarterial therapies
  • (no location specified)
Nov 27, 2022

HepaSphere Transarterial Chemoembolization Combined With Hepatic

Not yet recruiting
  • Colorectal Liver Metastases (CRCLM)
  • DEB-TACE plus HAIC
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 25, 2023

HepaSphere Drug-eluting Bead Transarterial Chemoembolization

Recruiting
  • Advanced Hepatocellular Carcinoma (HCC)
  • DEB-TACE plus HAIC or HAIC alone
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 19, 2023

Hepatocellular Carcinoma Trial in Nanning (Transarterial chemoembolization, Radiotherapy)

Recruiting
  • Hepatocellular Carcinoma
  • Transarterial chemoembolization
  • Radiotherapy
  • Nanning, Guangxi, China
    Department of Hepatobilliary Surgery, Affiliated Tumor of Guangx
Jan 25, 2023

Antibiotic Prophylaxis Trial in Lahore (Ceftriaxone Sodium)

Recruiting
  • Antibiotic Prophylaxis
  • Ceftriaxone Sodium
  • Lahore, Punjab, Pakistan
    Pakistan Kidney and Liver Institute
Dec 8, 2022

Hepatocellular Carcinoma Trial in New Delhi (N Acetylcysteine, Dexamethasone, Placebo)

Not yet recruiting
  • Hepatocellular Carcinoma
  • N Acetylcysteine
  • +2 more
  • New Delhi, Delhi, India
    Institute of Liver & Biliary Sciences
Sep 8, 2023

Gastric Cancer, Embolization Trial (Transarterial Chemoembolization)

Not yet recruiting
  • Gastric Cancer
  • Embolization
  • Transarterial Chemoembolization
  • (no location specified)
May 17, 2022

Child-Pugh Class A, Child-Pugh Class B, Recurrent Hepatocellular Carcinoma Trial in Palo Alto, Sapporo (radiation, procedure,

Active, not recruiting
  • Child-Pugh Class A
  • +2 more
  • Stereotactic Body Radiation Therapy
  • +3 more
  • Palo Alto, California
  • +1 more
Sep 9, 2022

Malignant Pleural Mesothelioma, Mesothelioma Trial in Tampa (Cisplatin, Methotrexate, Gemcitabine)

Active, not recruiting
Has Results
  • Malignant Pleural Mesothelioma
  • Mesothelioma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 5, 2023

Hepatocellular Carcinoma, Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma Trial in Dallas (Atezolizumab and

Not yet recruiting
  • Hepatocellular Carcinoma
  • Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma
  • Atezolizumab and bevacizumab
  • transarterial chemoembolization (TACE) or transarterial radioembolization (TARE
  • Dallas, Texas
    Simmons Comprehensive Cancer Center at University of Texas South
Sep 9, 2022

Carcinoma, Hepatocellular, Hepatic Carcinoma, Hepatocellular Cancer Trial in Hannover (Nivolumab, TACE)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • +2 more
  • Hannover, Germany
    Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
Nov 21, 2022

Hepatocellular Carcinoma, Cholangiocarcinoma, Metastatic Colon Cancer Trial in Milan (Embolization)

Recruiting
  • Hepatocellular Carcinoma
  • +6 more
  • Embolization
  • Milan, Italy
    IRCCS Ospedale San Raffaele
Feb 3, 2023

Hepatocellular Carcinoma, Bilirubinemia Trial in Minneapolis (Transarterial chemoembolization)

Completed
  • Hepatocellular Carcinoma
  • Bilirubinemia
  • Transarterial chemoembolization
  • Minneapolis, Minnesota
    University of Minnesota
Mar 18, 2022

Unresectable Hepatocellular Carcinoma Trial (Donafenib plus Sintilimab in combination with transarterial chemoembolisation)

Not yet recruiting
  • Unresectable Hepatocellular Carcinoma
  • Donafenib plus Sintilimab in combination with transarterial chemoembolisation
  • (no location specified)
Aug 17, 2022

Advanced Hepatocellular Carcinoma Trial in Guangzhou (drug, procedure, radiation)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Oct 20, 2022

Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial run by the NCI (durvalumab,

Recruiting
  • Hepatocellular Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Hepatocellular Carcinoma, Liver Cancer Trial in Seoul (IDA-TACE, DOX-TACE)

Recruiting
  • Hepatocellular Carcinoma
  • Liver Cancer
  • IDA-TACE
  • DOX-TACE
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 27, 2023

Hepatocellular Carcinoma Trial (Holmium-166 treatment, Holmium-166 work-up)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Holmium-166 treatment
  • Holmium-166 work-up
  • (no location specified)
Jul 6, 2022

Hepatocellular Carcinoma Non-resectable, Transarterial Chemoembolization, Tyrosine Kinase Inhibitor Trial in Chengdu (lenvatinib

Enrolling by invitation
  • Hepatocellular Carcinoma Non-resectable
  • +3 more
  • lenvatinib + sindilimab/carrelizumab
  • TACE
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
May 23, 2022

Hepatocellular Carcinoma Trial in Nanjing (cTACE(conventional transarterial chemoembolization))

Recruiting
  • Hepatocellular Carcinoma
  • cTACE(conventional transarterial chemoembolization)
  • Nanjing, Jiangsu, China
    Zhongda Hospital, Southeast University
Dec 28, 2022